These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15711561)

  • 1. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.
    Ito H; Koefoed M; Tiyapatanaputi P; Gromov K; Goater JJ; Carmouche J; Zhang X; Rubery PT; Rabinowitz J; Samulski RJ; Nakamura T; Soballe K; O'Keefe RJ; Boyce BF; Schwarz EM
    Nat Med; 2005 Mar; 11(3):291-7. PubMed ID: 15711561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of rAAV-caAlk2 coating on structural allograft healing.
    Koefoed M; Ito H; Gromov K; Reynolds DG; Awad HA; Rubery PT; Ulrich-Vinther M; Soballe K; Guldberg RE; Lin AS; O'Keefe RJ; Zhang X; Schwarz EM
    Mol Ther; 2005 Aug; 12(2):212-8. PubMed ID: 16043092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in gene delivery for structural bone allografts.
    Awad HA; Zhang X; Reynolds DG; Guldberg RE; O'Keefe RJ; Schwarz EM
    Tissue Eng; 2007 Aug; 13(8):1973-85. PubMed ID: 17518728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.
    Basile P; Dadali T; Jacobson J; Hasslund S; Ulrich-Vinther M; Søballe K; Nishio Y; Drissi MH; Langstein HN; Mitten DJ; O'Keefe RJ; Schwarz EM; Awad HA
    Mol Ther; 2008 Mar; 16(3):466-73. PubMed ID: 18180771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo.
    Ren WP; Markel DC; Zhang R; Peng X; Wu B; Monica H; Wooley PH
    Biomaterials; 2006 Oct; 27(30):5161-9. PubMed ID: 16814378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
    Fazzalari NL; Kuliwaba JS; Atkins GJ; Forwood MR; Findlay DM
    J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
    Theoleyre S; Wittrant Y; Tat SK; Fortun Y; Redini F; Heymann D
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):457-75. PubMed ID: 15561602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
    Ulrich-Vinther M
    Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].
    Ferrer Cañabate J; Tovar I; Martínez P
    An Med Interna; 2002 Aug; 19(8):385-88. PubMed ID: 12244784
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
    Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
    J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
    Galeano M; Deodato B; Altavilla D; Squadrito G; Seminara P; Marini H; Stagno d'Alcontres F; Colonna M; Calò M; Lo Cascio P; Torre V; Giacca M; Venuti FS; Squadrito F
    Crit Care Med; 2003 Apr; 31(4):1017-25. PubMed ID: 12682466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory mechanism of bone resorption: roles of bone remodeling-regulatory cytokines 'osteokines' in osteoclast differentiation and function].
    Kobayashi Y; Takahashi N
    Nihon Rinsho; 2003 Feb; 61(2):200-6. PubMed ID: 12638208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings.
    Yazici C; Yanoso L; Xie C; Reynolds DG; Samulski RJ; Samulski J; Yannariello-Brown J; Gertzman AA; Zhang X; Awad HA; Schwarz EM
    Biomaterials; 2008 Oct; 29(28):3882-7. PubMed ID: 18590929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.
    Fan X; Roy E; Zhu L; Murphy TC; Ackert-Bicknell C; Hart CM; Rosen C; Nanes MS; Rubin J
    Endocrinology; 2004 Feb; 145(2):751-9. PubMed ID: 14563699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual growth factor delivery from biofunctionalized allografts: Sequential VEGF and BMP-2 release to stimulate allograft remodeling.
    Sharmin F; McDermott C; Lieberman J; Sanjay A; Khan Y
    J Orthop Res; 2017 May; 35(5):1086-1095. PubMed ID: 27155087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.
    Yazici C; Takahata M; Reynolds DG; Xie C; Samulski RJ; Samulski J; Beecham EJ; Gertzman AA; Spilker M; Zhang X; O'Keefe RJ; Awad HA; Schwarz EM
    Mol Ther; 2011 Aug; 19(8):1416-25. PubMed ID: 21206485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus-mediated vascular endothelial growth factor gene therapy in skeletal muscle before transplantation promotes revascularization of regenerating muscle.
    Smythe GM; Lai MC; Grounds MD; Rakoczy PE
    Tissue Eng; 2002 Oct; 8(5):879-91. PubMed ID: 12459067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.
    Hofbauer LC; Schoppet M
    JAMA; 2004 Jul; 292(4):490-5. PubMed ID: 15280347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.